Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v4-FR
Language French French
Date Updated 2020-04-08 2020-03-31
Drug Identification Number 01977563 01977563
Brand name TRIAMCINOLONE ACETONIDE SUSPENSION TRIAMCINOLONE ACETONIDE SUSPENSION
Common or Proper name TRIAMCINOLONE ACETONIDE SUSPENSION TRIAMCINOLONE ACETONIDE SUSPENSION
Company Name STERIMAX INC STERIMAX INC
Ingredients TRIAMCINOLONE ACETONIDE TRIAMCINOLONE ACETONIDE
Strength(s) 40MG 40MG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR
Packaging size 1 VIAL 200 MG / 5 ML 1 VIAL 200 MG / 5 ML
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-09 2020-03-09
Estimated end date Unknown Unknown
Actual end date 2020-04-07
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product is available at McKesson at 50% allocation.
Health Canada comments